Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
165M
-
Shares change
-
+290K
-
Total reported value, excl. options
-
$608M
-
Value change
-
+$1.96M
-
Put/Call ratio
-
0.94
-
Number of buys
-
83
-
Number of sells
-
-73
-
Price
-
$3.69
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2023
192 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2023.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 165M shares
of 237M outstanding shares and own 69.54% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.4M shares), VANGUARD GROUP INC (12.4M shares), PERCEPTIVE ADVISORS LLC (11.9M shares), STATE STREET CORP (10.5M shares), Stonepine Capital Management, LLC (8.79M shares), Nuveen Asset Management, LLC (8.56M shares), D. E. Shaw & Co., Inc. (8.17M shares), Magnetar Financial LLC (6.04M shares), AWM Investment Company, Inc. (6.02M shares), and Assenagon Asset Management S.A. (5.64M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.